USP Medicare Model Guidelines v6.0 (Categories and Classes)
|
|
|
- Abner Howard
- 10 years ago
- Views:
Transcription
1 USP Medicare Model Guidelines v6.0 (Categories and Classes) USP Category Analgesics Nonsteroidal Anti-inflammatory Drugs Opioid Analgesics, Long-acting Opioid Analgesics, Short-acting Anesthetics Local Anesthetics Anti-Addiction/ Substance Abuse Treatment Agents Alcohol Deterrents/Anti-craving Opioid Dependence Treatments Opioid Reversal Agents Smoking Cessation Agents Antibacterials Aminoglycosides Beta-lactam, Cephalosporins Beta-lactam, Penicillins Beta-lactam, Other
2 Macrolides Quinolones Sulfonamides Tetracyclines Antibacterials, Other Anticonvulsants Calcium Channel Modifying Agents Gamma-aminobutyric Acid (GABA) Augmenting Agents Glutamate Reducing Agents Sodium Channel Agents Anticonvulsants, Other Antidementia Agents Cholinesterase Inhibitors N-methyl-D-aspartate (NMDA) Receptor Antagonist Antidementia Agents, Other Antidepressants Monoamine Oxidase Inhibitors
3 SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors) Tricyclics Antidepressants, Other Antiemetics Emetogenic Therapy Adjuncts Antiemetics, Other Antifungals Antigout Agents Anti-inflammatory Agents Glucocorticoids Nonsteroidal Anti-inflammatory Drugs Antimigraine Agents Ergot Alkaloids Serotonin (5-HT) 1b/1d Receptor Agonists Prophylactic Antimyasthenic Agents
4 Parasympathomimetics Antimycobacterials Antituberculars Antimycobacterials, Other Antineoplastics Alkylating Agents Antiandrogens Antiangiogenic Agents Antiestrogens/Modifiers Antimetabolites Aromatase Inhibitors, 3rd Generation Enzyme Inhibitors Molecular Target Inhibitors Monoclonal Antibodies Retinoids Antineoplastics, Other Antiparasitics
5 Anthelmintics Antiprotozoals Pediculicides/Scabicides Antiparkinson Agents Anticholinergics Dopamine Agonists Dopamine Precursors/ L-Amino Acid Decarboxylase Inhibitors Monoamine Oxidase B (MAO-B) Inhibitors Antiparkinson Agents, Other Antipsychotics 1st Generation/Typical 2nd Generation/Atypical Treatment-Resistant Antispasticity Agents Antivirals Anti-cytomegalovirus (CMV) Agents Anti-hepatitis B (HBV) Agents
6 Anti-hepatitis C (HCV) Agents Antiherpetic Agents Anti-HIV Agents, Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Anti-HIV Agents, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTI) Anti-HIV Agents, Protease Inhibitors Anti-HIV Agents, Integrase Inhibitors (INSTI) Anti-HIV Agents, Other Anti-influenza Agents Anxiolytics SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors) Benzodiazepines Anxiolytics, Other Bipolar Agents Mood Stabilizers Bipolar Agents, Other
7 Blood Glucose Regulators Antidiabetic Agents Glycemic Agents Insulins Blood Products/Modifiers/ Volume Expanders Anticoagulants Blood Formation Modifiers Coagulants Platelet Modifying Agents Cardiovascular Agents Alpha-adrenergic Agonists Alpha-adrenergic Blocking Agents Angiotensin-converting Enzyme (ACE) Inhibitors Angiotensin II Receptor Antagonists Antiarrhythmics Beta-adrenergic Blocking Agents Calcium Channel Blocking Agents
8 Diuretics, Carbonic Anhydrase Inhibitors Diuretics, Loop Diuretics, Potassium-sparing Diuretics, Thiazide Dyslipidemics, Fibric Acid Derivatives Dyslipidemics, HMG CoA Reductase Inhibitors Dyslipidemics, Other Vasodilators, Direct-acting Arterial Vasodilators, Direct-acting Arterial/Venous Cardiovascular Agents, Other Central Nervous System Agents Attention Deficit Hyperactivity Disorder Agents, Amphetamines Attention Deficit Hyperactivity Disorder Agents, Nonamphetamines Fibromyalgia Agents Multiple Sclerosis Agents Central Nervous System, Other Dental and Oral Agents
9 Dermatological Agents Enzyme Replacement/ Modifiers Gastrointestinal Agents Antispasmodics, Gastrointestinal Histamine2 (H2) Receptor Antagonists Irritable Bowel Syndrome Agents Laxatives Protectants Proton Pump Inhibitors Gastrointestinal Agents, Other Genitourinary Agents Antispasmodics, Urinary Benign Prostatic Hypertrophy Agents Phosphate Binders Genitourinary Agents, Other Hormonal Agents, Stimulant/ Replacement/ Modifying (Adrenal)
10 Hormonal Agents, Stimulant/Replacement/ Modifying (Pituitary) Hormonal Agents, Stimulant/ Replacement/ Modifying (Prostaglandins) Hormonal Agents, Stimulant/ Replacement/ Modifying (Sex Hormones/ Modifiers) Anabolic Steroids Androgens Estrogens Progesterone Agonists/Antagonists Progestins Selective Estrogen Receptor Modifying Agents Hormonal Agents, Stimulant/Replacement/ Modifying (Thyroid) Hormonal Agents, Suppressant (Adrenal) Hormonal Agents, Suppressant (Parathyroid) Hormonal Agents, Suppressant (Pituitary) Hormonal Agents, Suppressant (Thyroid)
11 Antithyroid Agents Immunological Agents Angioedema (HAE) Agents Immune Suppressants Immunizing Agents, Passive Immunomodulators Vaccines Inflammatory Bowel Disease Agents Glucocorticoids Aminosalicylates Sulfonamides Metabolic Bone Disease Agents Ophthalmic Agents Ophthalmic Anti-allergy Agents Ophthalmic Antiglaucoma Agents Ophthalmic Anti-inflammatories Ophthalmic Prostaglandin and Prostamide Analogs
12 Ophthalmic Agents, Other Otic Agents Respiratory Tract/ Pulmonary Agents Antihistamines Anti-inflammatories, Inhaled Corticosteroids Antileukotrienes Bronchodilators, Anticholinergic Bronchodilators, Sympathomimetic Cystic Fibrosis Agents Mast Cell Stabilizers Phosphodiesterase Inhibitors, Airways Disease Pulmonary Antihypertensives Respiratory Tract Agents, Other Skeletal Muscle Relaxants Sleep Disorder Agents GABA Receptor Modulators Sleep Disorders, Other
13 Therapeutic Nutrients/ Minerals/ Electrolytes Electrolyte/Mineral Modifiers Electrolyte/Mineral Replacement Vitamins
WESTCHESTER COMMUNITY COLLEGE Valhalla, NY 10595. COURSE TITLE: Pharmacology (for Nursing and Health Fields) COURSE NUMBER: Biology 202
WESTCHESTER COMMUNITY COLLEGE Valhalla, NY 10595 SYLLABUS FORM COURSE TITLE: Pharmacology (for Nursing and Health Fields) COURSE NUMBER: Biology 202 1. NAME OF COURSE: Pharmacology (for Nursing and Health
Illinois Department of Revenue Regulations TITLE 86: REVENUE CHAPTER I: DEPARTMENT OF REVENUE
Illinois Department of Revenue Regulations Title 86 Part 530 Section 530.110 Covered Prescription Drugs TITLE 86: REVENUE CHAPTER I: DEPARTMENT OF REVENUE PART 530 SENIOR CITIZENS AND DISABLED PERSONS
Pharmacology 260 Online Course Schedule Spring 2012
Pharmacology 260 Online Course Spring 2012 The topics listed below do not necessarily correspond to a 1 - hour lecture period. You should cover the topics for each week at some time during that week. Readings
BAPTIST HEALTH MEDICATION EXAMINATION INFORMATION SHEET
BAPTIST HEALTH MEDICATION EXAMINATION INFORMATION SHEET Before you begin employment in the role of RN or LPN, you are required to take a Medication Administration Exam. The exam may be administered at
GPI CLASSIFICATION REPORT
GPI CLASSIFICATION REPORT NAME CODE ADHD/ANTI-NARCOLEPSY/ANTI-OBESITY/ANOREXIANTS 6100000000 2 digit 1 ALTERNATIVE MEDICINES 9500000000 2 digit 2 AMEBICIDES 1400000000 2 digit 3 AMINOGLYCOSIDES 0700000000
1. The potential sites of action for sympathomimetics and the difference between a direct and indirect acting agonist.
1 OBI 836 The Autonomic Nervous System-Sympathomimetics M.T. Piascik August 29, 2012 Learning Objectives Lecture II The student should be able to explain or describe 1. The potential sites of action for
Contra Costa Regional Medical Center and Health Centers
Contra Costa Regional Medical Center and Health Centers Nurse Practitioner Standardized Procedures Table of Contents Definitions..2 References, Purpose, Method of Document Development.. 3 Qualifications,
Health Careers. Course Syllabus and Outline. PHARMACOLOGY FOR NURSES Nursing 220 ONLINE COURSE
HACC Central Pennsylvania s Community College Health Careers Course Syllabus and Outline PHARMACOLOGY FOR NURSES Nursing 220 ONLINE COURSE Professor: Margaret Gingrich I. Course Pharmacology for Nurses;
PROFESSIONAL BOARD FOR EMERGENCY CARE
PROFESSIONAL BOARD FOR EMERGENCY CARE IMPORTANT NOTICE TO ALL EMERGENCY CARE PRACTITIONERS INTRODUCTION OF NEW SCOPE OF PRACTICE FOR REGISTERED EMERGENCY CARE PRACTITIONERS NOVEMBER 2009 Herewith the July
Pharmacology - Problem Drill 06: Autonomic Pharmacology - Adrenergic System
Pharmacology - Problem Drill 06: Autonomic Pharmacology - Adrenergic System Question No. 1 of 10 Instructions: (1) Read the problem and answer choices carefully, (2) Work the problems on paper as 1. What
MEDICARE MODERNIZATION ACT FINAL GUIDELINES -- FORMULARIES CMS
MEDICARE MODERNIZATION ACT FINAL GUIDELINES -- FORMULARIES CMS Strategy for Affordable Access to Comprehensive Drug Coverage Guidelines for Reviewing Prescription Drug Plan Formularies and Procedures 1.
HEdis Code Quick Reference Guide Disease Management Services
HEdis Code Quick Reference Guide Disease Management Services Respiratory Conditions Appropriate Testing for Children With Pharyngitis (ages 2-18) [Commercial, Medicaid] Appropriate Treatment (no antibiotic)
Good Review Practice. October 2009 Labeling
Guidance for Industry and Review Staff Labeling for Human Prescription Drug and Biological Products Determining Established Pharmacologic Class for Use in the Highlights of Prescribing Information Good
Herbal Remedies and Prescription Medications
Herbal Remedies and Prescription Medications Herbal medicines are increasingly popular, but many patients do not inform their physicians that they are using these alternative remedies, according to one
NAP 117 MEDICATION ASSISTANT COURSE
NAP 117 MEDICATION ASSISTANT COURSE APPROVED: JANUARY 12, 2012 EFFECTIVE: FALL 2012-13 Prefix & Number NAP 117 Course Title: Medication Assistant Course Purpose of this submission: New Course New Change/Updated
Anatomical Therapeutic Chemical (ATC) classification and the Defined Daily Dose (DDD): principles for classifying and quantifying drug use
Anatomical Therapeutic Chemical (ATC) classification and the Defined Daily Dose (DDD): principles for classifying and quantifying drug use DRAFT Yong Chen Merck, Whitehouse Station, NJ USA Disclosure Author
PHARM 726. FUNDAMENTAL PHARMACOLOGY
PHARM 726. FUNDAMENTAL PHARMACOLOGY Course Description: A basic pharmacology course in which principles underlying the actions of drugs are presented, including pharmacokinetics, drug-receptor interactions,
Drug Treatment in Gynaecology Second edition
-2992 Drug Treatment in Gynaecology Second edition Rodney S. Ledward, BSC, DA, MB, chb, LRCP, MRCS, MRSH, DM, FRCS, FRCOG, DHMSA, MRPharm Soc. Consultant Obstetrician and Gynaecologist, South East Kent
Healthcare Effectiveness Data and Information Set (HEDIS ) Guide
Healthcare Effectiveness Data and Information Set (HEDIS ) Guide Clinical ALL ADULTS Access to preventive/ ambulatory health services Smoking and Tobacco Use Cessation [S] Aspirin Use and Discussion [S]
ICD 9 to ICD 10 Code Conversions Based on 2014 GEMs Alcohol and Drug Abuse Programs Approved ICD 10 Codes 3/21/2014
291 Alcohol induced mental disorders 291.0 Alcohol withdrawal delirium F10.231 Alcohol dependence with withdrawal delirium F10.121 Alcohol abuse with intoxication delirium F10.221 Alcohol dependence with
Hormones & Chemical Signaling
Hormones & Chemical Signaling Part 2 modulation of signal pathways and hormone classification & function How are these pathways controlled? Receptors are proteins! Subject to Specificity of binding Competition
Drugs, The Brain, and Behavior
Drugs, The Brain, and Behavior John Nyby Department of Biological Sciences Lehigh University What is a drug? Difficult to define Know it when you see it Neuroactive vs Non-Neuroactive drugs Two major categories
MEDICATION AND LABORATORY MONITORING
MEDICATION AND LABORATORY MONITORING GEM Conference 2013 September 17th, 2013 Clara Tsang RN (EC) Agenda Background Pharmacology Issues Among the Elderly Clinical Management & Medication Issues Diagnostic
Introduction to Animal Systems
Human Body Systems Introduction to Animal Systems Recurring Themes in Biology 1. Correlation between structure and function( seen at many levels) 2. Life is organized at many levels from Smallest ----
Chapter 28. Drug Treatment of Parkinson s Disease
Chapter 28 Drug Treatment of Parkinson s Disease 1. Introduction Parkinsonism Tremors hands and head develop involuntary movements when at rest; pin rolling sign (finger and thumb) Muscle rigidity arthritis
The Testosterone Report
The Testosterone Report Contents 1. What is Testosterone? 2. Why is Testosterone necessary? 3. Why do my Testosterone Levels decrease? 4. What does low Testosterone cause? 5. How Do I raise my Testosterone?
Treatments for Major Depression. Drug Treatments The two (2) classes of drugs that are typical antidepressants are:
Treatments for Major Depression Drug Treatments The two (2) classes of drugs that are typical antidepressants are: 1. 2. These 2 classes of drugs increase the amount of monoamine neurotransmitters through
COURSE SYLLABUS DH340-3 Pharmacology & Pain Control
COURSE SYLLABUS DH340-3 Pharmacology & Pain Control COURSE NO., HOURS AND TITLE: DH 340-3 Dental Pharmacology & Pain Control COURSE INSTRUCTORS: OFFICE HOURS: Danna P. Cotner, DDS Clinical Assistant Professor,
Drug Use Among Seniors on Public Drug Programs in Canada, 2012
Drug Use Among Seniors on Public Drug Programs in Canada, 2012 Report May 2014 Types of Care Our Vision Better data. Better decisions. Healthier Canadians. Our Mandate To lead the development and maintenance
Handbook for Community Pharmacy Practice
Handbook for Community Pharmacy Practice (PHR 1101, 2103, 3106, 4112) Co-ordinators: Professor Anthony Serracino-Inglott Professor Lilian M. Azzopardi Department of Pharmacy University of Malta October
OGB PELICAN HSA 775 COMPREHENSIVE CDHP MEDICAL BENEFIT PLAN SCHEDULE OF BENEFITS
OGB PELICAN HSA 775 COMPREHENSIVE CDHP MEDICAL BENEFIT PLAN SCHEDULE OF BENEFITS Nationwide Network Coverage Preferred Care Providers and BCBS National Providers BENEFIT PLAN FORM NUMBER 40HR1697 R03/15
Pharmacological CLASSIFICATION OF DRUGS. with Doses and Preparations
Pharmacological CLASSIFICATION OF DRUGS with Doses and Preparations Pharmacological CLASSIFICATION OF DRUGS with Doses and Preparations THIRD EDITION KD Tripathi MD Ex-Director-Professor and Head of Pharmacology
Social phobia following maprotiline: The first case report. Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran
Social phobia following maprotiline: The first case report Seyed Hamzeh Hosseini (MD) 1*, Ebraheim Salehifar (PharmD) 2 1* Associate professor of Psychiatry, Department of Psychiatry, Faculty of Medicine,
Clock Hours I General Concepts of Pharmacy 1-4 80. III Pharmacy Billing, Repacking and Compounding 9-12 80
PHARMACY TECHNICIAN (PHT) 720 clock hours/ 9 months (Total time to complete the program may vary based on school holidays and breaks) 28 weeks Theory/Lab (20 hours per week) + 8 weeks externship (20 hours
Functional Medicine University s Functional Diagnostic Medicine Training Program INSIDER S GUIDE
Functional Medicine University s Functional Diagnostic Medicine Training Program INSIDER S GUIDE Interpretation and treatment: male hormone profile By Ron Grisanti, D.C. & Dicken Weatherby, N.D. http://www.functionalmedicineuniversity.com
ADRENERGIC RECEPTOR AGONIST,CLASSIFICATION AND MECHANISM OF ACTION.
ADRENERGIC RECEPTOR AGONIST,CLASSIFICATION AND MECHANISM OF ACTION. LEARNING OBJECTIVES At the end of lecture students should be able to know, Adrenergic receptor agonist, Classification and mechanism
Chapter 20 USE OF DRUGS FOR NEUROLOGICAL DISORDER
Chapter 20 USE OF DRUGS FOR NEUROLOGICAL DISORDER Sapiah S. 1, Mohd. Sufian A. 1, Norsima Nazifah S. 2, Nurul Faezah M.Y. 2, Khutrun Nada Z. 1, Md. Hanip M.R. 1 1. Kuala Lumpur Hospital, Kuala Lumpur,
Compare the physiologic responses of the respiratory system to emphysema, chronic bronchitis, and asthma
Chapter 31 Drugs Used to Treat Lower Respiratory Disease Learning Objectives Describe the physiology of respirations Compare the physiologic responses of the respiratory system to emphysema, chronic bronchitis,
Adrenergic receptors lec 9, part 2. 16/10/2014 Dr. Laila M. Matalqah Rama Kamal Ali Treany
Adrenergic receptors lec 9, part 2 16/10/2014 Dr. Laila M. Matalqah Rama Kamal Ali Treany Pharmacology of ANS Adrenergic Agonists Adrenergic receptors:- - It is a receptor which is located in the peripheral
Prescribed Drug Spending in Canada, 2013: A Focus on Public Drug Programs
Prescribed Drug Spending in Canada, 2013: A Focus on Public Drug Programs Spending and Health Workforce Our Vision Better data. Better decisions. Healthier Canadians. Our Mandate To lead the development
Milwaukee School of Engineering [email protected]. Case Study: Factors that Affect Blood Pressure Instructor Version
Case Study: Factors that Affect Blood Pressure Instructor Version Goal This activity (case study and its associated questions) is designed to be a student-centered learning activity relating to the factors
ORGANIC MEDICINAL AND PHARMACEUTICAL CHEMISTRY
Wilson and Gisvold s Textbook of ORGANIC MEDICINAL AND PHARMACEUTICAL CHEMISTRY T W E L F T H E D I T I O N Edited by, PhD Associate Professor of Medicinal Chemistry Division of Basic and Pharmaceutical
Clinical Quality Measure Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW
Clinical Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW NQF 0105 PQRS 9 NQF 0002 PQRS 66 Antidepressant Medication Management Appropriate Testing for Children with Pharyngitis (2-18 years)
Philip Moore DO, Toxicology Fellow, PinnacleHealth Toxicology Center Joanne Konick-McMahan RN MSRN, Staff RN, PinnacleHealth
Philip Moore DO, Toxicology Fellow, PinnacleHealth Toxicology Center Joanne Konick-McMahan RN MSRN, Staff RN, PinnacleHealth I. II. Background A. AWS can occur in anyone who consumes alcohol B. Risk correlates
Depression is a common biological brain disorder and occurs in 7-12% of all individuals over
Depression is a common biological brain disorder and occurs in 7-12% of all individuals over the age of 65. Specific groups have a much higher rate of depression including the seriously medically ill (20-40%),
Column1 Substance Abuse Diagnosis Exclusion Codes ICD-9: Description 291.0 Alcohol withdrawal delirium 291.1 Alcohol-induced persisting amnestic
Column1 Substance Abuse Diagnosis Exclusion Codes ICD-9: Code Description 291.0 Alcohol withdrawal delirium 291.1 Alcohol-induced persisting amnestic disorder 291.2 Alcohol-induced persisting dementia
Excerpt from Food-Medication Interactions 13th edition by Zaneta M. Pronsky, MS, RD, LDN, FADA INTRODUCTION
Excerpt from Food-Medication Interactions 13th edition by Zaneta M. Pronsky, MS, RD, LDN, FADA INTRODUCTION The study of the absorption, distribution, metabolism and excretion of drugs is referred to as
Why Meditation is successful in Substance abuse treatment. Mediation paired with substance abuse treatment has been around since 1982 when the
Stone Amber Stone Mathew Arndt HLTH-1240 26 June 2014 Why Meditation is successful in Substance abuse treatment. Mediation paired with substance abuse treatment has been around since 1982 when the Betty
Managing Chronic Pain in Adults with Substance Use Disorders
Question from chapter 1 Managing Chronic Pain in Adults with Substance Use Disorders 1) What is the percent of chronic pain patients who may have addictive disorders? a) 12% b) 22% c) 32% d) 42% 2) Which
Research Article Drug Utilization Study in Medical Emergency Unit of a Tertiary Care Hospital in North India
Emergency Medicine International, Article ID 973578, 5 pages http://dx.doi.org/10.1155/2014/973578 Research Article Drug Utilization Study in Medical Emergency Unit of a Tertiary Care Hospital in North
Perioperative Medication Management
CARDIOVASCULAR Beta blockers (metoprolol, atenolol, others) Should be continued until and including the day of Ace inhibitors (ACEI) & Angiotensin receptor blockers (ARB) (captopril, lisinopril, losartan,
Chapter 20: Antimicrobial Drugs
Chapter 20: Antimicrobial Drugs 1. Overview of Antimicrobial Drugs 2. Antibacterial Drugs 3. Antiviral Drugs 4. Drugs for Eukaryotic Pathogens 1. Overview of Antimicrobial Drugs Antibiotics An antibiotic
DRUG UTILISATION STUDY IN BRONCHIAL ASTHMA IN A TERTIARY CARE HOSPITAL
International Journal of Pharmaceutical Applications ISSN 0976-2639, Online ISSN 2278 6023 Vol 3, Issue 2, 2012, pp 297-305 http://www.bipublication.com DRUG UTILISATION STUDY IN BRONCHIAL ASTHMA IN A
MA 2000 Pharmacology for Medical Assistants
South Central College MA 2000 Pharmacology for Medical Assistants Course Information Description Total Credits 3.00 Total Hours 64.00 Types of Instruction In this course students will learn topics essential
Hormonal Cycles. 1. Briefly describe each component of an endocrine feedback loop: Stimulus. Production Cell. Hormone. Target Cell. Target Cell Action
Hormonal Cycles Directions: a. Click the Contents button. b. Open the Endocrine System File. c. Click Animations. d. Click Hormonal Cycles. 1. Briefly describe each component of an endocrine feedback loop:
Chronic Kidney Disease and Diabetes
Anyone with diabetes can get kidney disease. Diabetes and high blood pressure are the most common causes of kidney disease, and people often have both. Chronic (long term) kidney disease (CKD) caused by
ORGAN SYSTEMS OF THE BODY
ORGAN SYSTEMS OF THE BODY DEFINITIONS AND CONCEPTS A. Organ a structure made up of two or more kinds of tissues organized in such a way that they can together perform a more complex function that can any
Chapter 4. The Adrenal Medulla
Chapter 4 The Adrenal Medulla Introduction Induction of cortisol production requires several minutes, and full elaboration of cortisol action requires several hours. In contrast, the adrenal medullary
ACOEM Commercial Driver Medical Examiner Training Program. Module 8: Drug Abuse & Alcoholism, Medication Use
ACOEM Commercial Driver Medical Examiner Training Program Module 8: Drug Abuse & Alcoholism, Medication Use Drug Abuse - 49 CFR 391.41(b)(12)i)(ii)(A)(B) "A person is physically qualified to drive a commercial
Preventive Care Recommendations THE BASIC FACTS
Preventive Care Recommendations THE BASIC FACTS MULTIPLE SCLEROSIS Carlos Healey, diagnosed in 2001 The Three Most Common Eye Disorders in Multiple Sclerosis Blood Pressure & Pulse Height & Weight Complete
Data Based Medicine Paper: Dependence and Withdrawal
Data Based Medicine Paper: Dependence and Withdrawal Author: Dr. David Healy Date Last Revised: 7 June 2012 Contents TREATMENT GROUPS... 2 DRUG GROUPS... 2 ALL DRUGS ACT ON EVERYTHING... 3 DRUG WITHDRAWAL
Advanced Treatment for Opioid & Alcohol Dependence. John Larson, M.D. Corporate Medical Director Gateway Foundation
Advanced Treatment for Opioid & Alcohol Dependence John Larson, M.D. Corporate Medical Director Gateway Foundation Background 41 years practicing psychiatry Last 15 in addiction medicine I ve watched a
Administering Medications
Administering Medications Pharmacology for Healthcare Professionals seventh edition Donna F. Gauwitz, R.N., Nursing Consultant Senior Teaching Specialist of Nursing University of Minnesota Minnesota and
The Endocrine System
Essentials of Human Anatomy & Physiology Elaine N. Marieb Seventh Edition Chapter 9 The Endocrine System Slides 9.1 9.48 Lecture Slides in PowerPoint by Jerry L. Cook The Endocrine System Second messenger
Hormone Restoration: Is It Right for You? Patricia A. Stafford, M.D. Founder, Wellness ReSolutions
Hormone Restoration: Is It Right for You? Patricia A. Stafford, M.D. Founder, Wellness ReSolutions IMPORTANCE OF HORMONE BALANCE Importance of Hormone Balance Help you live a long, healthy life Help you
Key Points. Autonomic Nervous System Drugs. Autonomic effects Sympathetic. Drugs can modify ANS activity by: Autonomic Nervous System
Key Points Autonomic Nervous System Drugs Autonomic drugs work at the synapses, Drugs either suppress or magnify the sympathetic or parasympathetic effect, Drugs don t work on a single target organ so
BSc in Medical Sciences with PHARMACOLOGY
BSc in Medical Sciences with PHARMACOLOGY Course Director Dr Christopher John Module Leaders Dr Robert Dickinson (Module 1) Dr Anabel Varela Carver (Module 2) Dr Sohag Saleh (Module 3) Course Administrator
Sponsored by: 2013 NAMI Maryland Conference Baltimore, Maryland; Friday, October 18 th, 2013
Integrated System of Care Universal Dual Diagnosis Capabilities Principles of Empathy and Hope Motivational Interviewing Approach Stages of Change Model Design Solution Focused Strength Based Skill Building
Endocrine System: Practice Questions #1
Endocrine System: Practice Questions #1 1. Removing part of gland D would most likely result in A. a decrease in the secretions of other glands B. a decrease in the blood calcium level C. an increase in
POPULAR DEPRESSION MEDICATIONS
Popular Depression Medications A Helpful Guide to Antidepressant Drugs POPULAR DEPRESSION MEDICATIONS A Helpful Guide to Antidepressant Drugs Popular Depression Medications A Helpful Guide to Antidepressant
Endocrine Responses to Resistance Exercise
chapter 3 Endocrine Responses to Resistance Exercise Chapter Objectives Understand basic concepts of endocrinology. Explain the physiological roles of anabolic hormones. Describe hormonal responses to
POST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics
POST-TEST University of Wisconsin Hospital & Clinics True/False/Don't Know - Circle the correct answer T F D 1. Changes in vital signs are reliable indicators of pain severity. T F D 2. Because of an underdeveloped
PHC 313 The 7 th. Lecture. Adrenergic Agents
PHC 313 The 7 th. Lecture Adrenergic Agents Introduction Introduction Adrenergic agents are a broad class of agents employed in the treatment of many disorders. They are those chemical agents that exert
Medications for chronic pain
Medications for chronic pain When it comes to treating chronic pain with medications, there are many to choose from. Different types of pain medications are used for different pain conditions. You may
MEASURING CARE QUALITY
MEASURING CARE QUALITY Region November 2015 For Clinical Effectiveness of Care Measures of Performance From: Healthcare Effectiveness Data and Information Set (HEDIS ) HEDIS is a set of standardized performance
Coding and Payment Guide for Laboratory Services. An essential coding, billing, and payment resource for laboratory and pathology services
Coding and Payment Guide for Laboratory Services An essential coding, billing, and payment resource for laboratory and pathology services Contents Introduction............................... 1 Coding Systems...............................
KEY CHAPTER 14: BLOOD OBJECTIVES. 1. Describe blood according to its tissue type and major functions.
KEY CHAPTER 14: BLOOD OBJECTIVES 1. Describe blood according to its tissue type and major functions. TISSUE TYPE? MAJOR FUNCTIONS connective Transport Maintenance of body temperature 2. Define the term
Brain Damage & Recovery: The Resilience of the Brain, Addiction Impact & Therapeutic Repair. Michael Fishman, MD Director of Young Adult Program
Brain Damage & Recovery: The Resilience of the Brain, Addiction Impact & Therapeutic Repair Michael Fishman, MD Director of Young Adult Program How Addiction Takes Hold Large & rapid upsurges in dopamine
Urinary System. And Adrenal Function
Urinary System And Adrenal Function Overview Kidney anatomy and physiology Urine Ureters, Bladder and Urethra Adrenal Function Functions of the Kidney Filter fluids from the blood Regulate volume and composition
Shared Care Agreement Insulin Degludec (Tresiba )
Licensed Indication Shared Care Agreement Insulin Degludec (Tresiba ) Insulin Degludec is licensed for the treatment of diabetes mellitus in adults. Countess of Chester prescribing guidelines Restricting
Prescribed Drug Spending in Canada, 2012: A Focus on Public Drug Programs
Prescribed Drug Spending in Canada, 2012: A Focus on Public Drug Programs Spending and Health Workforce Our Vision Better data. Better decisions. Healthier Canadians. Our Mandate To lead the development
SECTION N: MEDICATIONS. N0300: Injections. Item Rationale Health-related Quality of Life. Planning for Care. Steps for Assessment. Coding Instructions
SECTION N: MEDICATIONS Intent: The intent of the items in this section is to record the number of days, during the last 7 days (or since admission/reentry if less than 7 days) that any type of injection,
regulation of ECF composition and volume regulation of metabolism thyroid hormones, epinephrine, growth hormone, insulin and glucagon
Hormonal Effects regulation of ECF composition and volume ADH, aldosterone, ANF regulation of metabolism thyroid hormones, epinephrine, growth hormone, insulin and glucagon regulation of muscle contraction
NATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Vitamin D and Bone Health CE APPLICATION FORM
NATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Vitamin D and Bone Health CE APPLICATION FORM First Name: Last Name: Mailing Address: City: State: Zip/Postal Code: Country: Phone Number:
EXECUTIVE BLOOD WORK PANEL
EXECUTIVE BLOOD WORK PANEL Below is a list of all blood and urine testing done on the day of your Executive Medical. MALE Serum Glucose Random Serum Glucose Fasting Creatinine Uric Acid Sodium Potassium
